查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1467848

2024-2032 年静脉治疗和静脉通路市场（按类型、应用、最终用户和地区）

Intravenous Therapy and Vein Access Market by Type, Application, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 140 Pages | 商品交期: 2-3个工作天内

价格

2023 年，全球静脉 (IV) 治疗和静脉通路市场规模达到 251 亿美元。 展望未来， IMARC Group预计到 2032 年，市场规模将达到 382 亿美元，2024 年复合年增长率 (CAGR) 为 4.64%。 2032.慢性病盛行率不断上升、交通事故发生率不断上升，以及消费者对静脉注射疗法益处的认识不断提高，是推动市场发展的一些关键因素。

静脉 (IV) 治疗是一种医疗程序，涉及透过静脉将液体、药物和营养物质直接注射到血液中。此技术通常用于医院、诊所和其他医疗机构来治疗各种病症和疾病。静脉通路是进入静脉进行静脉注射治疗的过程。医疗保健专业人员通常使用针刺穿皮肤并进入静脉，由于静脉细小或受损、脱水和肥胖等因素，这对某些患者来说可能具有挑战性。静脉注射疗法有多种类型，包括用于脱水的盐水溶液、用于感染的抗生素以及用于癌症治疗的化学治疗。除了治疗疾病外，静脉注射疗法还可以用于预防措施，例如接种疫苗和维生素。

静脉 (IV) 治疗和静脉通路市场趋势：

癌症、糖尿病和自体免疫疾病等慢性病和生活方式疾病的盛行率不断上升，需要长期用药和监测，这主要推动了全球静脉 (IV) 治疗和静脉通路市场的成长。除此之外，道路事故发生率的上升和创伤病例的激增也促进了市场的成长。此外，消费者对静脉注射治疗和静脉通路益处的认识不断提高，以及重症监护治疗的兴起，为市场带来了有利可图的成长机会。与此一致的是，对微创手术的偏好的转变是另一个重要的成长诱导因素。除此之外，医疗保健行业的许多技术进步减少了所需的时间和精力，降低了感染风险并提高了手术的准确性，正在为市场创造积极的前景。同时，对创新疗法、药物和设备的研发（R&D）活动的​​大量投资也有助于市场扩张。此外，医疗保健支出的增加、医院数量的增加、家庭医疗保健的广泛采用以及老年人口的扩大正在加强市场的成长。

本报告回答的关键问题：

  • 迄今为止，全球静脉 (IV) 治疗和静脉通路市场的表现如何，未来几年将如何表现？
  • 全球静脉 (IV) 治疗和静脉通路市场的驱动因素、限制因素和机会是什么？
  • 每个驱动因素、限制因素和机会对全球静脉 (IV) 治疗和静脉通路市场有何影响？
  • 主要区域市场有哪些？
  • 哪些国家代表了最具吸引力的静脉 (IV) 治疗和静脉通路市场？
  • 依类型划分市场是怎么样的？
  • 静脉 (IV) 治疗和静脉通路市场中哪种类型最具吸引力？
  • 基于应用的市场区隔是什么？
  • 静脉 (IV) 治疗和静脉通路市场中哪项应用最具吸引力？
  • 基于最终用户的市场区隔是什么？
  • 哪一个是静脉 (IV) 治疗和静脉通路市场中最具吸引力的最终用户？
  • 全球静脉（IV）治疗和静脉通路市场的竞争结构如何？
  • 全球静脉 (IV) 治疗和静脉通路市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球静脉 (IV) 治疗与静脉通路市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：按类型

  • 植入式连接埠
    • 市场走向
    • 市场预测
  • 静脉导管
    • 市场走向
    • 市场预测
  • 皮下注射针
    • 市场走向
    • 市场预测
  • 点滴帮浦
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 7 章：市场区隔：按应用

  • 营养及缓衝液
    • 市场走向
    • 市场预测
  • 音量扩展器
    • 市场走向
    • 市场预测
  • 药物管理
    • 市场走向
    • 市场预测
  • 血液製品
    • 市场走向
    • 市场预测

第 8 章：市场区隔：依最终用户

  • 医院
    • 市场走向
    • 市场预测
  • 门诊手术中心
    • 市场走向
    • 市场预测
  • 诊所
    • 市场走向
    • 市场预测

第 9 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场走向
    • 市场细分：按国家/地区
    • 市场预测

第 10 章：驱动因素、限制与机会

  • 概述
  • 司机
  • 限制
  • 机会

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • AngioDynamics Inc.
    • B. Braun Melsungen AG
    • Baxter International Inc.
    • Becton Dickinson and Company
    • Cardinal Health Inc.
    • Fresenius SE & Co. KGaA
    • ICU Medical Inc.
    • Medtronic plc
    • Tekni-Plex Inc.
    • Teleflex Incorporated
    • Terumo Corporation
    • Vygon SAS
Product Code: SR112024A7524

The global intravenous (IV) therapy and vein access market size reached US$ 25.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 38.2 Billion by 2032, exhibiting a growth rate (CAGR) of 4.64% during 2024-2032. The growing prevalence of chronic diseases, the increasing incidences of road accidents, and the rising consumer awareness about the benefits of IV therapy represent some of the key factors driving the market.

Intravenous (IV) therapy is a medical procedure that involves administering fluids, medications, and nutrition directly into the bloodstream through a vein. This technique is commonly used in hospitals, clinics, and other healthcare facilities to treat various conditions and illnesses. Vein access is the process of entering a vein in order to administer IV therapy. A healthcare professional typically uses a needle to puncture the skin and access a vein, which can be challenging in some patients due to factors such as small or damaged veins, dehydration, and obesity. There are several types of IV therapy, including saline solutions for dehydration, antibiotics for infections, and chemotherapy for cancer treatment. In addition to treating medical conditions, IV therapy can also be used for preventative measures, such as receiving vaccinations and vitamins.

Intravenous (IV) Therapy and Vein Access Market Trends:

The increasing prevalence of chronic and lifestyle diseases, such as cancer, diabetes, and autoimmune diseases that require long-term medication and monitoring, is primarily driving the global intravenous (IV) therapy and vein access market growth. Besides this, the rising incidences of road accidents and the surging number of trauma cases are contributing to the market growth. Moreover, the escalating consumer awareness about the benefits of IV therapy and vein access and the rise in critical care therapies are presenting remunerative growth opportunities for the market. In line with this, the shifting preference for minimally invasive procedures is acting as another significant growth-inducing factor. In addition to this, numerous technological advancements in the healthcare industry to reduce the needed time and effort, lower the risk of infection, and improve the accuracy of the procedure are creating a positive outlook for the market. Concurrent with this, extensive investments in research and development (R&D) activities for innovating new therapies, drugs, and devices are aiding in market expansion. Furthermore, the increasing healthcare expenditure, rise in the number of hospitals, the widespread adoption of home healthcare, and the expanding geriatric population are strengthening the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global intravenous (IV) therapy and vein access market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on type, application, and end user.

Type Insights:

Implantable Ports

Intravenous Catheters

Hypodermic Needles

Infusion Pumps

Others

The report has provided a detailed breakup and analysis of the intravenous (IV) therapy and vein access market based on the type. This includes implantable ports, intravenous catheters, hypodermic needles, infusion pumps, and others. According to the report, intravenous catheters represented the largest segment.

Application Insights:

Nutrition and Buffer Solution

Volume Expander

Medication Administration

Blood Based Products

A detailed breakup and analysis of the intravenous (IV) therapy and vein access market based on the application has also been provided in the report. This includes nutrition and buffer solution, volume expander, medication administration, and blood-based products. According to the report, medication administration accounted for the largest market share.

End User Insights:

Hospitals

Ambulatory Surgical Center

Clinics

The report has provided a detailed breakup and analysis of the intravenous (IV) therapy and vein access market based on the end user. This includes hospitals, ambulatory surgical centers, and clinics. According to the report, hospitals represented the largest segment.

Regional Insights:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for intravenous (IV) therapy and vein access. Some of the factors driving the North America intravenous (IV) therapy and vein access market included the growing prevalence of chronic diseases, the increasing number of road accidents, and the expanding geriatric population.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global intravenous (IV) therapy and vein access market. Detailed profiles of all major companies have also been provided. Some of the companies covered include AngioDynamics Inc., B. Braun Melsungen AG, Baxter International Inc., Becton Dickinson and Company, Cardinal Health Inc., Fresenius SE & Co. KGaA, ICU Medical Inc., Medtronic plc, Tekni-Plex Inc., Teleflex Incorporated, Terumo Corporation, Vygon SAS, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global intravenous (IV) therapy and vein access market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global intravenous (IV) therapy and vein access market?
  • What is the impact of each driver, restraint, and opportunity on the global intravenous (IV) therapy and vein access market?
  • What are the key regional markets?
  • Which countries represent the most attractive intravenous (IV) therapy and vein access market?
  • What is the breakup of the market based on the type?
  • Which is the most attractive type in the intravenous (IV) therapy and vein access market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the intravenous (IV) therapy and vein access market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the intravenous (IV) therapy and vein access market?
  • What is the competitive structure of the global intravenous (IV) therapy and vein access market?
  • Who are the key players/companies in the global intravenous (IV) therapy and vein access market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Intravenous (IV) Therapy and Vein Access Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Implantable Ports
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Intravenous Catheters
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Hypodermic Needles
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Infusion Pumps
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Nutrition and Buffer Solution
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Volume Expander
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Medication Administration
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Blood Based Products
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ambulatory Surgical Center
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Clinics
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

  • 10.1 Overview
  • 10.2 Drivers
  • 10.3 Restraints
  • 10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 AngioDynamics Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 B. Braun Melsungen AG
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Baxter International Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Becton Dickinson and Company
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Cardinal Health Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Fresenius SE & Co. KGaA
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 ICU Medical Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Medtronic plc
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Tekni-Plex Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Teleflex Incorporated
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Terumo Corporation
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Vygon SAS
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

  • Figure 1: Global: Intravenous Therapy and Vein Access Market: Major Drivers and Challenges
  • Figure 2: Global: Intravenous Therapy and Vein Access Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Intravenous Therapy and Vein Access Market: Breakup by Type (in %), 2023
  • Figure 5: Global: Intravenous Therapy and Vein Access Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Intravenous Therapy and Vein Access Market: Breakup by End User (in %), 2023
  • Figure 7: Global: Intravenous Therapy and Vein Access Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Intravenous Therapy and Vein Access (Implantable Ports) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Intravenous Therapy and Vein Access (Implantable Ports) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Intravenous Therapy and Vein Access (Intravenous Catheters) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Intravenous Therapy and Vein Access (Intravenous Catheters) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Intravenous Therapy and Vein Access (Hypodermic Needles) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Intravenous Therapy and Vein Access (Hypodermic Needles) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Intravenous Therapy and Vein Access (Infusion Pumps) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Intravenous Therapy and Vein Access (Infusion Pumps) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Intravenous Therapy and Vein Access (Other Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Intravenous Therapy and Vein Access (Other Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Intravenous Therapy and Vein Access (Nutrition and Buffer Solution) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Intravenous Therapy and Vein Access (Nutrition and Buffer Solution) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Intravenous Therapy and Vein Access (Volume Expander) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Intravenous Therapy and Vein Access (Volume Expander) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Intravenous Therapy and Vein Access (Medication Administration) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Intravenous Therapy and Vein Access (Medication Administration) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Intravenous Therapy and Vein Access (Blood Based Products) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Intravenous Therapy and Vein Access (Blood Based Products) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Intravenous Therapy and Vein Access (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Intravenous Therapy and Vein Access (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Intravenous Therapy and Vein Access (Ambulatory Surgical Center) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Intravenous Therapy and Vein Access (Ambulatory Surgical Center) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Intravenous Therapy and Vein Access (Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Intravenous Therapy and Vein Access (Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: North America: Intravenous Therapy and Vein Access Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: North America: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: United States: Intravenous Therapy and Vein Access Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: United States: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Canada: Intravenous Therapy and Vein Access Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Canada: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Asia-Pacific: Intravenous Therapy and Vein Access Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Asia-Pacific: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: China: Intravenous Therapy and Vein Access Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: China: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Japan: Intravenous Therapy and Vein Access Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Japan: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: India: Intravenous Therapy and Vein Access Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: India: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: South Korea: Intravenous Therapy and Vein Access Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: South Korea: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Australia: Intravenous Therapy and Vein Access Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Australia: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Indonesia: Intravenous Therapy and Vein Access Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Indonesia: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Others: Intravenous Therapy and Vein Access Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Others: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Europe: Intravenous Therapy and Vein Access Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Europe: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Germany: Intravenous Therapy and Vein Access Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Germany: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: France: Intravenous Therapy and Vein Access Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: France: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: United Kingdom: Intravenous Therapy and Vein Access Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: United Kingdom: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Italy: Intravenous Therapy and Vein Access Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Italy: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Spain: Intravenous Therapy and Vein Access Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Spain: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Russia: Intravenous Therapy and Vein Access Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Russia: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Others: Intravenous Therapy and Vein Access Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Others: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Latin America: Intravenous Therapy and Vein Access Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Latin America: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Brazil: Intravenous Therapy and Vein Access Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Brazil: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Mexico: Intravenous Therapy and Vein Access Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Mexico: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Others: Intravenous Therapy and Vein Access Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Others: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Middle East and Africa: Intravenous Therapy and Vein Access Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Middle East and Africa: Intravenous Therapy and Vein Access Market: Breakup by Country (in %), 2023
  • Figure 80: Middle East and Africa: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Global: Intravenous Therapy and Vein Access Industry: Drivers, Restraints, and Opportunities
  • Figure 82: Global: Intravenous Therapy and Vein Access Industry: Value Chain Analysis
  • Figure 83: Global: Intravenous Therapy and Vein Access Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Intravenous Therapy and Vein Access Market: Key Industry Highlights, 2023 & 2032
  • Table 2: Global: Intravenous Therapy and Vein Access Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Intravenous Therapy and Vein Access Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Intravenous Therapy and Vein Access Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 5: Global: Intravenous Therapy and Vein Access Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Intravenous Therapy and Vein Access Market: Competitive Structure
  • Table 7: Global: Intravenous Therapy and Vein Access Market: Key Players